Q1 Earnings Forecast for MacroGenics Issued By HC Wainwright
MacroGenics, Inc. (NASDAQ:MGNX – Free Report) – Equities researchers at HC Wainwright raised their Q1 2025 EPS estimates for shares of MacroGenics in a research note issued to investors on Tuesday, March 25th. HC Wainwright analyst R. Burns now forecasts that the biopharmaceutical company will earn ($0.69) per share for the quarter, up from their […]
